3MC-20570-72501
3 vaccinations
1 coded response
15 check-ins
1 free-text entry
0 call cases
- Sex
- Female
- Age at first dose
- 26-30
- ZIP prefix
- 520 / IA
- Registered
- 2021-12-07
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-03-31
Dose 1 — Pfizer-BioNTech
-
2021-04-21
Dose 2 — Pfizer-BioNTech
-
2021-12-07
Registered in v-safe
-
2021-12-07
Dose 3 — Pfizer-BioNTech
- 2021-12-07
-
2021-12-08
Health check-in — days 1–6 daily, dose 3Feeling: Good · Site: Pain · Fatigue or tirednessAdult check-in
- 2021-12-09
-
2021-12-10
Health check-in — days 1–6 daily, dose 3Feeling: Good · Muscle or body aches, Fatigue or tirednessAdult check-in
- 2021-12-11
- 2021-12-12
- 2021-12-13
- 2021-12-14
- 2021-12-21
- 2021-12-28
-
2022-01-04
Survey response — day 28, dose 3MedDRA: Cough, Nasopharyngitis, Rhinorrhoea — Feeling: FairFree text: Cold symptoms-cough, runny nose etc.MedDRA releases: 2024-11 · check-in free text available
- 2022-01-13
- 2022-01-18
- 2022-03-08
- 2022-06-07
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-31 | Pfizer-BioNTech | No |
| 2 | 2021-04-21 | Pfizer-BioNTech | No |
| 3 | 2021-12-07 | Pfizer-BioNTech | No |
Free text
Release 10 — day 28, dose 3
Symptoms: Cold symptoms-cough, runny nose etc.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Cough | · | · | ✓ |
| SD | Nasopharyngitis | · | · | ✓ |
| SD | Rhinorrhoea | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release